Get App Open
In App
Lending
Lending
Open App
you are here:

UTI Healthcare Fund - Growth

  • Regular
  • Direct
Category : Sectoral/Thematic
Fund House : UTI Mutual Fund
  • NAV
    : ₹ 292.7354 0.88%
    (as on 10th October, 2025)
Crisil Rating

Not Rated

Rank not available for the fund
Risk-O-Meter
Very High Risk

The fund has 98.99% investment in domestic equities of which 24.85% is in Large Cap stocks, 17.53% is in Mid Cap stocks, 18.77% in Small Cap stocks.

Suitable For : Investors who have advanced knowledge of macro trends and prefer to take selective bets for higher returns compared to other Equity funds. At the same time, these investors should also be ready for possibility of moderate to high losses in their investments even though overall market is performing better.

This Scheme
VS
  • Benchmark
    BSE Healthcare TRI
  • NA
  • NA
  • Gold
Compare with
  • Date : -
  • NAV : -
  • Date : -
  • Investment : -
  • Value on selected date : -
  • Returns Calculator
  • SIP Calculator
  • VIP (Value Avg)
Amount
  • Investment Date
  • Sell Date
  • Investment Value
    -
  • Sell Value
    -
  • Profit/Loss
    -
  • Annualised Returns
    -
  • Date : -
  • Investment : -
  • Value on selected date : -

Returns (NAV as on 10th October, 2025)

Period Invested for ₹10000 Invested on Latest Value Absolute Returns Annualised Returns Category Avg Rank within Category
1 Week 03-Oct-25 10193.90 1.94% - 1.04% 37/238
1 Month 10-Sep-25 9918.60 -0.81% - 0.77% 199/235
3 Month 10-Jul-25 10189.80 1.90% - 0.77% 64/226
6 Month 09-Apr-25 11513.40 15.13% - 16.54% 102/223
YTD 01-Jan-25 9963.90 -0.36% - 2.95% 135/212
1 Year 10-Oct-24 10130.50 1.31% 1.31% -1.11% 55/193
2 Year 10-Oct-23 15969.20 59.69% 26.33% 18.82% 14/150
3 Year 10-Oct-22 19319.80 93.20% 24.52% 19.51% 22/126
5 Year 09-Oct-20 22037.40 120.37% 17.10% 22.06% 77/102
10 Year 09-Oct-15 28725.10 187.25% 11.12% 14.07% 67/75
Since Inception 30-Jul-05 161375.60 1513.76% 14.75% 12.33% 95/214

SIP Returns (NAV as on 10th October, 2025)

Period Invested for ₹1000 SIP Started on Investments Latest Value Absolute Returns Annualised Returns
1 Year 10-Oct-24 12000 12587.1 4.89 % 9.17 %
2 Year 10-Oct-23 24000 28423.79 18.43 % 17.17 %
3 Year 10-Oct-22 36000 51035.28 41.76 % 24 %
5 Year 09-Oct-20 60000 97410.69 62.35 % 19.45 %
10 Year 09-Oct-15 120000 297030.77 147.53 % 17.25 %
 

Tax Treatment

If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.

Portfolio (Updated on 30th Sep,2025)

Equity Holding : 98.99% | F&O Holdings : 0.00%| Foreign Equity Holdings : 0.00%| Total : 98.99%
No of Stocks : 41 (Category Avg - 44.38) | Large Cap Investments : 24.85%| Mid Cap Investments : 17.53% | Small Cap Investments : 18.77% | Other : 37.84%

Top 10 Stocks in Portfolio

How to read this table?
Stock Invested in Sector Value(Mn) % of Total Holdings 1M Change 1Y Highest Holding 1Y Lowest Holding Quantity 1M Change in Qty
# Sun Pharmaceutical Industries Ltd. Pharmaceuticals 1053.9 9.61% 0.00% 11.88% (Apr 2025) 9.42% (Aug 2025) 6.61 L 0.00
# Ajanta Pharma Limited Pharmaceuticals 601.6 5.48% 0.00% 5.38% (Oct 2024) 4.09% (May 2025) 2.50 L 7.33 k
# Cipla Ltd. Pharmaceuticals 601.3 5.48% 0.00% 6.2% (Sep 2024) 5.43% (Jul 2025) 4.00 L 0.00
# Lupin Ltd. Pharmaceuticals 516.1 4.70% 0.00% 4.57% (Aug 2025) 0% (Sep 2024) 2.70 L 0.00
# Procter & Gamble Health Ltd. Pharmaceuticals 437.2 3.99% 0.00% 4.34% (May 2025) 3.14% (Dec 2024) 69.32 k -0.72 k
# Glenmark Pharmaceuticals Ltd. Pharmaceuticals 410.1 3.74% 0.00% 4.07% (Mar 2025) 3.49% (Sep 2024) 2.10 L -0.10 L
# Dr. Reddys Laboratories Ltd. Pharmaceuticals 409.9 3.74% 0.00% 5.28% (Dec 2024) 3.99% (Jul 2025) 3.35 L -0.25 L
# Gland Pharma Ltd. Pharmaceuticals 396.9 3.62% 0.00% 3.85% (Nov 2024) 2.43% (Apr 2025) 1.99 L 0.00
# Apollo Hospitals Enterprises Ltd. Hospital 392.7 3.58% 0.00% 3.88% (Sep 2024) 3.22% (Feb 2025) 53.00 k 0.00
# Alkem Laboratories Ltd. Pharmaceuticals 390.6 3.56% 0.00% 3.41% (Aug 2025) 1.92% (May 2025) 72.00 k 0.00
- indicates change in weight in the portfolio. # indicates a new entry.
Name Type of Instrument Weight (%)
Net Receivables Net Receivables 1.00%
Margin Margin 0.01%

Risk Ratios

Ratios calculated on daily returns for last 3 years (Updated as on 30th September, 2025)

  • Standard Deviation

    Low volatility
    11.45vs12.57
    Category Avg
  • Beta

    Low volatility
    0.61vs0.86
    Category Avg
  • Sharpe Ratio

    Better risk adjusted returns
    1.43vs1.01
    Category Avg
  • Treynor's Ratio

    Better risk adjusted returns
    0.27vs0.18
    Category Avg
  • Jensen's Alpha

    Better risk adjusted returns
    11.25vs3.66
    Category Avg

Alternative Funds (Category Peers)

Scheme Name
Crisil Rank
Asset Size (Cr)
1M
3M
6M
1Y
3Y
Nippon India Taiwan Equity Fund - Regular Plan - Growth NA 406.67 1.29 24.23 116.57 46.39 36.14
Aditya Birla Sun Life International Equity Fund - Regular Plan - Growth NA 249.75 2.53 10.73 32.27 29.15 19.98
Franklin Asian Equity Fund - Growth NA 259.99 4.97 12.15 32.70 16.00 14.89
Nippon India US Equity Opportunities Fund - Growth NA 724.35 2.05 5.46 14.18 15.43 22.52
Nippon India Japan Equity Fund - Growth NA 283.56 -0.80 10.31 26.28 15.02 17.53
SBI Banking & Financial Services Fund - Regular Plan - Growth NA 8693.07 2.70 0.58 16.64 14.46 19.75
DSP Banking & Financial Services Fund - Regular Plan - Growth NA 1331.23 2.77 0.27 13.53 11.63 0.00
Motilal Oswal Business Cycle Fund - Regular Plan - Growth NA 1976.19 -0.43 2.01 21.15 11.34 0.00
ITI Banking and Financial Services Fund - Regular Plan - Growth NA 301.88 3.57 -0.18 12.43 11.24 14.34
WhiteOak Capital Banking & Financial Services Fund - Regular Plan - Growth NA 483.64 1.28 -0.21 13.85 10.92 0.00

More Funds from UTI Mutual Fund

Out of 96 mutual fund schemes offered by this AMC, 6 is/are ranked 5 * , 5 is/are ranked 4 * , 14 is/are ranked 3 * , 8 is/are ranked 2 * , 1 is/are ranked 1 * , and 62 schemes are not ranked. See more about AMC

Scheme Name
Crisil Rank
Asset Size (Cr)
1M
3M
6M
1Y
3Y
UTI Nifty 50 ETF 5 63831.92 1.24 0.04 13.82 2.38 14.85
UTI Nifty 50 ETF 5 63831.92 1.24 0.04 13.82 2.38 14.85
UTI BSE Sensex ETF 5 49897.45 1.32 -0.58 12.69 2.26 13.80
UTI BSE Sensex ETF 5 49897.45 1.32 -0.58 12.69 2.26 13.80
UTI Flexi Cap Fund - Growth 2 25187.42 -0.43 0.35 13.79 -0.55 11.21
UTI Liquid Fund - Regular Plan - Growth 2 25036.71 0.49 1.42 3.02 6.77 7.00
UTI Nifty 50 Index Fund - Growth 3 24335.81 1.22 -0.03 13.67 2.12 14.52
UTI Nifty 50 Index Fund - Growth 3 24335.81 1.25 0.04 13.84 2.42 14.92
UTI Money Market Fund - Regular Plan - Growth 3 20513.42 0.56 1.47 3.52 7.75 7.60
UTI Large Cap Fund - Growth 2 12946.56 0.87 0.26 12.37 -0.07 13.14

Forum

+ See More